Yawei Du
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Electrospun Nanofibers in Biomedical Applications
- Pharmaceutical Science top 5%
Papers in
-
- RNA Interference and Gene Delivery 16
- Lipid Membrane Structure and Behavior 9
- Extracellular vesicles in disease 5
- Cancer therapeutics and mechanisms 4
- Biomaterials 25
- Nanoparticle-Based Drug Delivery 21
- Co-authors
- Xinsong Li (29 shared papers)Chen Yao (19 shared papers)Wenguo Cui (38 shared papers)Longbing Ling (15 shared papers)Muhammad Ismail (13 shared papers)Wenya Zhou (11 shared papers)Wei He (14 shared papers)Chao Li (6 shared papers)
- Journals
- International Journal of Pharmaceutics (8 papers)Advanced Science (5 papers)Advanced Materials (5 papers)Advanced Functional Materials (4 papers)Small (4 papers)
- Partner nations
- ChinaBangladeshFinland
In The Last Decade
Yawei Du
68 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 118
- Biomaterials 531
- Pharmaceutical Science 109
- Molecular Medicine 66
- Biomedical Engineering 538
- Rheumatology 134
Countries citing papers authored by Yawei Du
This map shows the geographic impact of Yawei Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yawei Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yawei Du more than expected).
Fields of papers citing papers by Yawei Du
This network shows the impact of papers produced by Yawei Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yawei Du. The network helps show where Yawei Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Yawei Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 98 | |
| 2 | 2022 | 75 | |
| 3 | 2023 | 73 | |
| 4 | 2018 | 67 | |
| 5 | 2023 | 64 | |
| 6 | 2023 | 61 | |
| 7 | 2022 | 58 | |
| 8 | 2018 | 49 | |
| 9 | 2019 | 46 | |
| 10 | 2019 | 37 | |
| 11 | 2021 | 36 | |
| 12 | 2017 | 36 | |
| 13 | 2019 | 35 | |
| 14 | 2024 | 34 | |
| 15 | 2020 | 32 | |
| 16 | 2020 | 32 | |
| 17 | 2022 | 32 | |
| 18 | 2023 | 32 | |
| 19 | 2024 | 31 | |
| 20 | 2017 | 31 |
About Yawei Du
Yawei Du is a scholar working on Molecular Biology, Biomaterials, Biomedical Engineering, Surgery and Rheumatology, having authored 81 papers that have together received 1.5k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (21 papers), RNA Interference and Gene Delivery (16 papers), Nanoplatforms for cancer theranostics (13 papers), Lipid Membrane Structure and Behavior (9 papers), Bone Tissue Engineering Materials (8 papers), Graphene and Nanomaterials Applications (5 papers), Extracellular vesicles in disease (5 papers) and Cancer therapeutics and mechanisms (4 papers). The work is most often cited by research in Biomaterials (531 citations), Pharmaceutical Science (109 citations), Molecular Medicine (66 citations), Biomedical Engineering (538 citations) and Rheumatology (134 citations). Yawei Du has collaborated with scholars based in China, Bangladesh and Finland. Frequent co-authors include Xinsong Li, Chen Yao, Wenguo Cui, Longbing Ling, Muhammad Ismail, Wenya Zhou, Wei He, Chao Li, Wei Chen and Qing Xia. Their work appears in journals such as International Journal of Pharmaceutics, Advanced Science, Advanced Materials, Advanced Functional Materials and Small.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.